SCHEMBL16330685

SCHEMBL16330685

CCC(C)C(NC)C(=O)Nc1ncnc2c1c(C(N)=O)cn2[C@@H]1O[C@H](CO)C(O)[C@@H]1OC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 2/20 0.45
▸ TP53 P04637 1/20 0.45
▸ STAT6 P42226 1/20 0.45
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ ADK P55263 6/20 0.42
▸ PAX8 Q06710 2/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ GALR3 O60755 1/20 0.41
▸ S1PR4 O95977 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ S1PR1 P21453 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ ADORA3 P0DMS8 1/20 0.40
▸ HSPA8 P11142 1/20 0.38
▸ TMEM97 Q5BJF2 2/20 0.38
▸ OPRK1 P41145 1/20 0.38
▸ SIGMAR1 Q99720 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16330686 0.93 HIF1A (0.47) HIF1ATP53STAT6MEN1KMT2A
SCHEMBL16330692 0.91 HIF1A (0.54) HIF1ATP53STAT6ADKPAX8
SCHEMBL16330763 0.88 HIF1A (0.51) HIF1AMEN1KMT2AADKPAX8
SCHEMBL16330758 0.88 HIF1A (0.40) HIF1ATP53STAT6ADKPAX8
SCHEMBL16330764 0.87 TP53 (0.46) HIF1ATP53STAT6MEN1KMT2A
SCHEMBL16330684 0.84 HIF1A (0.56) HIF1ATP53STAT6ADKPAX8
SCHEMBL16330756 0.82 ADK (0.46) HIF1ATP53STAT6ADK
SCHEMBL16330762 0.82 HIF1A (0.48) HIF1ATP53STAT6MEN1KMT2A
SCHEMBL16330693 0.81 HIF1A (0.53) HIF1ATP53STAT6MEN1KMT2A
SCHEMBL16330759 0.81 HIF1A (0.41) HIF1ATP53STAT6ADKPAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130018010-A1 POLYMERIC CONJUGATES OF ADENINE NUCLEOSIDE ANALOGS ENZON PHARMACEUTICALS, INC. (US) 2013-01-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130018010-A1 POLYMERIC CONJUGATES OF ADENINE NUCLEOSIDE ANALOGS VEGFA, MKI67, PCNA HIF1A 922/4885TP53 282/4885STAT6 4220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback